XNW28012
/ Evopoint
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 13, 2025
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
(clinicaltrials.gov)
- P1/2 | N=200 | Recruiting | Sponsor: Evopoint Biosciences Inc. | Not yet recruiting ➔ Recruiting | Initiation date: Mar 2025 ➔ Dec 2023
Enrollment open • Trial initiation date • Cervical Cancer • Hepatology • Oncology • Ovarian Cancer • Pancreatic Cancer • Solid Tumor
January 29, 2025
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
(clinicaltrials.gov)
- P1/2 | N=200 | Not yet recruiting | Sponsor: Evopoint Biosciences Inc.
New P1/2 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1